Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colleen Burgess

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 22, 2011
Estimating the impact of human papillomavirus (HPV) vaccination on HPV prevalence and cervical cancer incidence in MaliLaRee Tracy, Holly D Gaff, Colleen Burgess, et al.
The Journal of Infectious Diseases|June 14, 2011
Global eradication of measles: an epidemiologic and economic evaluationAnn Levin, Colleen Burgess, Louis P Garrison, et al.
The Pediatric Infectious Disease Journal|August 6, 2024
Impact of the COVID-19 Pandemic on Measles Vaccination Coverage and Estimated Catch-up Efforts for SerbiaColleen Burgess, Bogdan Lisul, Manjiri Pawaskar, et al.
Human Vaccines & Immunotherapeutics|October 31, 2022
The health and economic impact of switching vaccines in universal varicella vaccination programs using a dynamic transmission model: An Israel case studyStephanie A Kujawski, Colleen Burgess, Oren Agi, et al.
Expert Review of Vaccines|May 22, 2026
Epidemiological impact of a 20- or 21-valent pneumococcal conjugate vaccine in the Japan adult population: insights from a dynamic transmission modelRachel J Oidtman, Atsushi Tajima, Taizo Matsuki, et al.
The Journal of Infectious Diseases|June 14, 2011
Assessing the cost-effectiveness of measles elimination in Uganda: local impact of a global eradication programJoseph B Babigumira, Ann Levin, Colleen Burgess, et al.
The Lancet. Global Health|September 16, 2022
Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling studyAmy K Winter, Brian Lambert, Daniel Klein, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 22, 2011
Estimating the impact of human papillomavirus (HPV) vaccination on HPV prevalence and cervical cancer incidence in MaliLaRee Tracy, Holly D Gaff, Colleen Burgess, et al.
The Journal of Infectious Diseases|June 14, 2011
Global eradication of measles: an epidemiologic and economic evaluationAnn Levin, Colleen Burgess, Louis P Garrison, et al.
The Pediatric Infectious Disease Journal|August 6, 2024
Impact of the COVID-19 Pandemic on Measles Vaccination Coverage and Estimated Catch-up Efforts for SerbiaColleen Burgess, Bogdan Lisul, Manjiri Pawaskar, et al.
Human Vaccines & Immunotherapeutics|October 31, 2022
The health and economic impact of switching vaccines in universal varicella vaccination programs using a dynamic transmission model: An Israel case studyStephanie A Kujawski, Colleen Burgess, Oren Agi, et al.
Expert Review of Vaccines|May 22, 2026
Epidemiological impact of a 20- or 21-valent pneumococcal conjugate vaccine in the Japan adult population: insights from a dynamic transmission modelRachel J Oidtman, Atsushi Tajima, Taizo Matsuki, et al.
The Journal of Infectious Diseases|June 14, 2011
Assessing the cost-effectiveness of measles elimination in Uganda: local impact of a global eradication programJoseph B Babigumira, Ann Levin, Colleen Burgess, et al.
The Lancet. Global Health|September 16, 2022
Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling studyAmy K Winter, Brian Lambert, Daniel Klein, et al.
Pageof 3